Vedat Hamuryudan

Summary

Country: Turkey

Publications

  1. ncbi request reprint Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study
    Vedat Hamuryudan
    Behçet s Syndrome Research Center, Cerrahpaa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Isr Med Assoc J 4:928-30. 2002
  2. doi request reprint Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial
    Vedat Hamuryudan
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Aksaray, 34365, Istanbul, Turkey
    Rheumatology (Oxford) 49:173-7. 2010
  3. doi request reprint Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients
    Emire Seyahi
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Medicine (Baltimore) 91:35-48. 2012
  4. ncbi request reprint Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial
    Vedat Hamuryudan
    From the Behçet s Syndrome Research Center, Istanbul University, Istanbul, Turkey
    J Rheumatol 41:735-8. 2014
  5. doi request reprint Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome
    Omer Ates
    Department of Molecular Biology and Genetics, Science Faculty, Istanbul University, Istanbul, Turkey
    Mol Biol Rep 37:3637-41. 2010
  6. doi request reprint The estimated pulmonary artery pressure can be elevated in Behçet's syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Respir Med 105:1739-47. 2011
  7. ncbi request reprint Behçet's syndrome: a critical digest of the 2012-2013 literature
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Clin Exp Rheumatol 31:108-17. 2013
  8. doi request reprint Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease
    Hasan Tuzun
    Department of Cardiovascular Surgery, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Vasc Surg 55:157-63. 2012
  9. ncbi request reprint Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study
    Melike Melikoglu
    The Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 32:98-105. 2005
  10. doi request reprint Atherosclerosis in Behçet's Syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Semin Arthritis Rheum 38:1-12. 2008

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study
    Vedat Hamuryudan
    Behçet s Syndrome Research Center, Cerrahpaa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Isr Med Assoc J 4:928-30. 2002
    ..Eye involvement is the main cause of morbidity in Behçet's syndrome. The efficacy of the combined use of azathioprine and interferon alfa in treating this condition has not been studied...
  2. doi request reprint Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial
    Vedat Hamuryudan
    Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical School, Istanbul University, Aksaray, 34365, Istanbul, Turkey
    Rheumatology (Oxford) 49:173-7. 2010
    ..To assess the influence of being free of major organ involvement during the early years of the disease on the prognosis of men with Behçet's syndrome (BS)...
  3. doi request reprint Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients
    Emire Seyahi
    Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Medicine (Baltimore) 91:35-48. 2012
    ..Corticosteroids and immunosuppressive agents are the mainstays of treatment; however, refractory cases may require embolization, lobectomy, cavitectomy, and decortication...
  4. ncbi request reprint Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial
    Vedat Hamuryudan
    From the Behçet s Syndrome Research Center, Istanbul University, Istanbul, Turkey
    J Rheumatol 41:735-8. 2014
    ..To test the hypothesis that colchicine use during early disease decreases immunosuppressive use in Behçet syndrome (BS) in the long term...
  5. doi request reprint Analyses of functional IL10 and TNF-α genotypes in Behçet's syndrome
    Omer Ates
    Department of Molecular Biology and Genetics, Science Faculty, Istanbul University, Istanbul, Turkey
    Mol Biol Rep 37:3637-41. 2010
    ..Our study indicates that functional TNF-α, IL10 genotypes or combined TNF-α, IL10 genotypes do not play a role in BS susceptibility in Turkish BS patients...
  6. doi request reprint The estimated pulmonary artery pressure can be elevated in Behçet's syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Respir Med 105:1739-47. 2011
    ....
  7. ncbi request reprint Behçet's syndrome: a critical digest of the 2012-2013 literature
    Gulen Hatemi
    Istanbul University, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey
    Clin Exp Rheumatol 31:108-17. 2013
    ..Switching to another biologic can be effective when the first or even the second biologic agent fails or is stopped due to adverse events. ..
  8. doi request reprint Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease
    Hasan Tuzun
    Department of Cardiovascular Surgery, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Vasc Surg 55:157-63. 2012
    ....
  9. ncbi request reprint Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study
    Melike Melikoglu
    The Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, Istanbul, Turkey
    J Rheumatol 32:98-105. 2005
    ..To determine the effect of the tumor necrosis factor-alpha blocker etanercept on the pathergy and monosodium urate (MSU) status and on the mucocutaneous and articular manifestations of patients with Behçet's disease (BD)...
  10. doi request reprint Atherosclerosis in Behçet's Syndrome
    Emire Seyahi
    Division of Rheumatology, Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Semin Arthritis Rheum 38:1-12. 2008
    ..Thus, we evaluated the presence of subclinical atherosclerosis in a sizeable group of patients with BS both with major organ involvement and mucocutaneous disease along with diseased and healthy controls...
  11. doi request reprint Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients
    Omer Ates
    Department of Molecular Biology and Genetics, Science Faculty, Istanbul University, 34118 Vezneciler, Istanbul, Turkey
    Clin Rheumatol 27:1243-8. 2008
    ..Our findings suggest that IL-10 1082 G/A polymorphism or GCC, ACC haplotypes may be associated with RA in Turkish patients...
  12. ncbi request reprint Pulmonary artery aneurysms in Behçet syndrome
    Vedat Hamuryudan
    Behçet s Syndrome Research Center, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
    Am J Med 117:867-70. 2004
  13. ncbi request reprint Headache in Behçet's syndrome
    Sabahattin Saip
    The Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Headache 45:911-9. 2005
    ..To study the frequencies and characteristics of different headache types seen in patients with Behçet's syndrome (BS) in a large cohort of patients...
  14. ncbi request reprint The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center
    Emire Kural-Seyahi
    Behçet Syndrome Research Center, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Medicine (Baltimore) 82:60-76. 2003
    ..There were no female patients with arterial aneurysms. Severely impaired vision did not always mean an eventual loss of useful vision, and those patients with a late onset of eye disease had a better visual prognosis...
  15. doi request reprint Genetic susceptibility to Behçet's syndrome is associated with NRAMP1 (SLC11A1) polymorphism in Turkish patients
    Omer Ates
    Department of Molecular Biology and Genetics, Science Faculty, Istanbul University, Vezneciler, 34118, Istanbul, Turkey
    Rheumatol Int 29:787-91. 2009
    ..Our study suggests that NRAMP1 may be one of the plausible candidate genes for BS. However, it is likely that INT4 polymorphism is not disease-specific and seems to be common to immune-mediated diseases...
  16. ncbi request reprint Behçet syndrome
    Sebahattin Yurdakul
    Division of Rheumatology, Department of Medicin, Cerrahpasa Medical Faculty, University of Istanbul, Turkey
    Curr Opin Rheumatol 16:38-42. 2004
    ..Interest in Behçet syndrome (BS), although the condition is rare in many parts of the world, is increasing as judged by the growing number of related publications and scientific meetings...
  17. doi request reprint Outcome measures used in clinical trials for Behçet syndrome: a systematic review
    Gulen Hatemi
    From the Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey Division of Rheumatology and Department of Epidemiology, University of Pennsylvania, Philadelphia, PA, USA Department of Clinical Epidemiology, VU University Medical Center, Amsterdam, the Netherlands Department of Rheumatology, Marmara University School of Medicine, Istanbul Department of Rheumatology, Istanbul Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey
    J Rheumatol 41:599-612. 2014
    ....
  18. doi request reprint Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis
    Arzu Seven
    Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Rheumatol Int 29:743-7. 2009
    ..ESR is positively correlated with DAS activity and CRP values. Our finding of no correlation between leptin and BMI shows that regulation of leptinemia is complex, and leptin levels cannot be used to assess RA activity...
  19. ncbi request reprint Superoxide dismutase activity and glutathione system in erythrocytes of men with Behchet's disease
    Yildiz Dincer
    Department of Biochemistry, Cerrahpasa Medical Faculty, Istanbul 34300, Turkey
    Tohoku J Exp Med 198:191-5. 2002
    ..It was concluded that erythrocyte SOD activity and glutathione system are altered in men with new diagnosed BD. It was concluded that these alterations may be a contributory factor for tissue damage associated with BD...